<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE:: We aimed to identify prognostic factors after pulmonary metastasectomy for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and propose the clinical application of them </plain></SENT>
<SENT sid="1" pm="."><plain>Furthermore, we endeavored to provide a rationale for pulmonary metastasesectomy </plain></SENT>
<SENT sid="2" pm="."><plain>BACKGROUND:: Several prognostic factors have been proposed, but clinical application of them remains unclear </plain></SENT>
<SENT sid="3" pm="."><plain>Moreover, there is no theoretical evidence that pulmonary metastasectomy is indicated for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS:: We retrospectively analyzed 1030 patients who underwent pulmonary metastasectomy for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> from 1990 to 2008 </plain></SENT>
<SENT sid="5" pm="."><plain>Prognostic factors were identified and the relationship of recurrent sites after pulmonary resection to pulmonary <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size was assessed </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS:: Overall 5-year survival was 53.5% </plain></SENT>
<SENT sid="7" pm="."><plain>Median survival time was 69.5 months </plain></SENT>
<SENT sid="8" pm="."><plain>Univariate analysis showed <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> number (P &lt; 0.0001), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size (P &lt; 0.0001), prethoracotomy serum carcinoembryonic antigen (CEA) level (P &lt; 0.0001), lymph node involvement (P &lt; 0.0001), and completeness of resection (P &lt; 0.0001) to significantly influence survival </plain></SENT>
<SENT sid="9" pm="."><plain>In multivariate analysis, <z:hpo ids='HP_0000001'>all</z:hpo> remained independent predictors of outcome </plain></SENT>
<SENT sid="10" pm="."><plain>In patients whose recurrent sites extended downstream from the lung via hematogenous <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> spread, pulmonary <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size was significantly larger than in those with recurrent sites confined to the lung and regions upstream from the lung </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS:: We should utilize these prognostic factors to detect patients who might benefit from surgery </plain></SENT>
<SENT sid="12" pm="."><plain>Therefore, we should periodically follow up advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients by chest computed tomography to detect small <z:e sem="disease" ids="C0153676" disease_type="Neoplastic Process" abbrv="">pulmonary metastases</z:e> before serum CEA elevation </plain></SENT>
<SENT sid="13" pm="."><plain><z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">Metastases</z:e> to the lung or organs upstream from the lung are regarded as semi-local for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>This concept provides a rationale for validating surgical indications for <z:e sem="disease" ids="C0153676" disease_type="Neoplastic Process" abbrv="">pulmonary metastases</z:e> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>